Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Two individuals with potential monkeypox virus reinfection.

ABSTRACT:

SUBMITTER: Raccagni AR

PROVIDER: S-EPMC10079276 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Two individuals with potential monkeypox virus reinfection.

Raccagni Angelo Roberto AR Canetti Diana D Mileto Davide D Tamburini Andrea Marco AM Candela Caterina C Albarello Luca L Bracchitta Fiorenza F Mancon Alessandro A Micheli Valeria V Gismondo Maria Rita MR Castagna Antonella A Nozza Silvia S

The Lancet. Infectious diseases 20230406 5

PMID: 37031694

Similar Datasets

Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals.

Project description:In early 2022, a cluster of monkeypox virus (MPXV) infection (mpox) cases were identified within the UK with no prior travel history to MPXV-endemic regions. Subsequently, case numbers exceeding 80,000 were reported worldwide, primarily affecting gay, bisexual, and other men who have sex with men (GBMSM). Public health agencies worldwide have offered the IMVANEX Smallpox vaccination to these individuals at high-risk to provide protection and limit the spread of MPXV. We have developed a comprehensive array of ELISAs to study poxvirus-induced antibodies, utilising 24 MPXV and 3 Vaccinia virus (VACV) recombinant antigens. Panels of serum samples from individuals with differing Smallpox-vaccine doses and those with prior MPXV infection were tested on these assays, where we observed that one dose of Smallpox vaccination induces a low number of antibodies to a limited number of MPXV antigens but increasing with further vaccination doses. MPXV infection induced similar antibody responses to diverse poxvirus antigens observed in Smallpox-vaccinated individuals. We identify MPXV A27 as a serological marker of MPXV-infection, whilst MPXV M1 (VACV L1) is likely IMVANEX-specific. Here, we demonstrate analogous humoral antigen recognition between both MPXV-infected or Smallpox-vaccinated individuals, with binding to diverse yet core set of poxvirus antigens, providing opportunities for future vaccine (e.g., mRNA) and therapeutic (e.g., mAbs) design.

| S-EPMC10517934 | biostudies-literature

Potential mechanisms of intrauterine transmission of monkeypox virus.

Project description: Not available

| S-EPMC9533917 | biostudies-literature